|
|
HOT TOPICS IN HYPERTENSION: Issue 10, 2010
Hypertension and the kidney: recent advances in renal protection with a focus on olmesartan medoxomil
Hypertension and the kidney: recent advances in renal protection with a focus on olmesartan medoxomil
Luis M. Ruilope, Julián Segura, José A. García-Donaire
Correspondence to:
José A. García-Donaire - MD Nephrologist Hypertension Unit Complutense University Hospital 12 de Octubre Madrid, Spain E-mail: docdonaire@terra.es
Summary
- RELATIONSHIP BETWEEN MINOR DERANGEMENTS IN RENAL FUNCTION AND CARDIOVASCULAR RISK – USEFUL INDICATORS
- Serum creatinine
- Microalbuminuria
- ASSOCIATION BETWEEN RENAL AND CARDIOVASCULAR DISEASE IN HYPERTENSIVE PATIENTS: CONTRIBUTION OF OLMESARTAN MEDOXOMIL
- Main conclusions from the most significant trials
- Influence of renal damage in CV prognosis
- EFFECT OF THE ANTAGONISM OF THE ANGIOTENSIN II SUBTYPE I RECEPTOR: CONTRIBUTION OF OLMESARTAN MEDOXOMIL
- Olmesartan medoxomil along the cardiorenal continuum
- Olmesartan medoxomil in diabetic nephropathy: data from the most recent trials
- SUMMARY
- REFERENCES
If you have a Username and Password, you may already access to this article. Please login below.
If you do not have a Username and Password, click the "Register" button below to purchase this article.
|
|